42 results on '"Variya, Bhavesh"'
Search Results
2. Corrigendum to “DEAE-Dextran coated paclitaxel nanoparticles act as multifunctional nano system for intranuclear delivery to triple negative breast cancer through VEGF and NOTCH1 inhibition” [Eur. J. Pharm. Biopharm. 122 (2018) 37–48]
3. Design and development of Tetrahydro-Quinoline derivatives as dual mTOR-C1/C2 inhibitors for the treatment of lung cancer
4. Profibrogenic role of IL-15 through IL-15 receptor alphamediated trans-presentation in the carbon tetrachlorideinduced liver fibrosis model.
5. Retraction Note to: Insights from diversified anti-angiogenic models: role of β-interferon inducer DEAE-Dextran
6. Corrigendum to “Suppression of abdominal fat and anti-hyperlipidemic potential of Emblica officinalis: Upregulation of PPARs and identification of active moiety” Biomed. Pharmacother. 108 (2018) 1274–1281
7. Acute and 28-days repeated dose sub-acute toxicity study of gallic acid in albino mice
8. Inflammation in human adipose tissues–Shades of gray, rather than white and brown
9. Cyclophilin inhibition with rencofilstat shifts the liver transcriptome and lipidome in preclinical models toward resolution of non-alcoholic steatohepatitis
10. One should avoid retro-orbital pharmacokinetic sample collections for intranasal dosing in rats: Illustration of spurious pharmacokinetics generated for anti-migraine drugs zolmitriptan and eletriptan
11. Repeated dose 28-day oral toxicity study of DEAE-Dextran in mice: An advancement in safety chemotherapeutics
12. Prognostic significance of SOCS1 and SOCS3 tumor suppressors and oncogenic signaling pathway genes in hepatocellular carcinoma
13. Insights from diversified anti-angiogenic models: Role of β-interferon inducer DEAE-Dextran
14. An improved method for isolation and flow cytometric characterization of intrahepatic leukocytes from fatty and fibrotic liver tissues
15. Synergistic anti-tumor activity with a combination of anti-PD1 antibody and the cyclophilin inhibitor, rencofilstat, in the Hep53.4 fatty liver model of hepatocellular carcinoma
16. Design, synthesis and pharmacological evaluation of novel substituted quinoline-2-carboxamide derivatives as human dihydroorotate dehydrogenase (hDHODH) inhibitors and anticancer agents
17. DEAE-Dextran coated paclitaxel nanoparticles act as multifunctional nano system for intranuclear delivery to triple negative breast cancer through VEGF and NOTCH1 inhibition
18. An improved method for isolation and flow cytometric characterization of intrahepatic leukocytes from fatty and fibrotic liver tissues.
19. Drug Design, Synthesis and Biological Evaluation of Heterocyclic Molecules as Anti-Inflammatory Agents
20. Comparative evaluation of HMG CoA reductase inhibitors in experimentally-induced myocardial necrosis: Biochemical, morphological and histological studies
21. WED-455 - Cyclophilin inhibition with rencofilstat shifts the liver transcriptome and lipidome in preclinical models toward resolution of non-alcoholic steatohepatitis
22. Antidiabetic potential of gallic acid from Emblica officinalis: Improved glucose transporters and insulin sensitivity through PPAR-γ and Akt signaling
23. Chemokines in human obesity
24. RETRACTED: Insights from diversified anti-angiogenic models: Role of β-interferon inducer DEAE-Dextran
25. Hepatocyte growth control by SOCS1 and SOCS3
26. Suppression of abdominal fat and anti-hyperlipidemic potential of Emblica officinalis: Upregulation of PPARs and identification of active moiety
27. Role of β-Interferon Inducer (DEAE-Dextran) in Tumorigenesis by VEGF and NOTCH1 Inhibition along with Apoptosis Induction
28. Liquid phase combinatorial synthesis of 1,2,5-trisubstituted benzimidazole derivatives as human DHODH inhibitors
29. DMBA- Induced Breast Cancer: A Hormonal Camouflage
30. Molecular docking, synthesis and biological screening of mefenamic acid derivatives as anti-inflammatory agents
31. IN SILICO MOLECULAR DOCKING AND PHARMACOKINETIC PREDICTION OF GALLIC ACID DERIVATIVES AS PPAR-γ AGONISTS
32. Novel targets for paclitaxel nano formulations: Hopes and hypes in triple negative breast cancer
33. Emblica officinalis (Amla): A review for its phytochemistry, ethnomedicinal uses and medicinal potentials with respect to molecular mechanisms
34. Synthesis, anti-inflammatory, analgesic, 5-lipoxygenase (5-LOX) inhibition activities, and molecular docking study of 7-substituted coumarin derivatives
35. Pharmacological Evaluation of Jambrushila Tablet on Animal Model of Type-2 Diabetes
36. Pharmacological Evaluation of Jambrushila Tablet on Animal Model of Type-2 Diabetes
37. Carboplatin-induced Fanconi-like syndrome in rats: Amelioration by pentoxifylline
38. RETRACTED ARTICLE: Insights from diversified anti-angiogenic models: Role of β-interferon inducer DEAE-Dextran
39. Galactomannan: A versatile biodegradable seed polysaccharide
40. DMBA- Induced Breast Cancer: A Hormonal Camouflage
41. Antidiabetic potential of gallic acid from Emblica officinalis: Improved glucose transporters and insulin sensitivity through PPAR-γ and Akt signaling.
42. An improved method for isolation and flow cytometric characterization of intrahepatic leukocytes from fatty and fibrotic liver tissues.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.